Breast Metastatic Marker Test: Your Path to Clarity and Confidence
When you’re navigating breast cancer concerns, uncertainty can feel overwhelming. Our Breast Metastatic Marker Test provides the precise information you and your healthcare team need to make informed decisions about your treatment journey. This comprehensive analysis offers peace of mind through advanced detection of potential metastasis, helping you stay one step ahead in your health management.
Understanding Your Breast Metastatic Marker Test
This specialised test examines three crucial markers that provide valuable insights into your breast cancer status:
- ER (Oestrogen Receptor): Determines if your cancer cells have oestrogen receptors, guiding hormone therapy decisions
- PR (Progesterone Receptor): Identifies progesterone receptors, further refining treatment options
- CA 15.3: Monitors cancer activity and potential spread through this important tumour marker
Each sample undergoes professional pathology review to confirm the presence of malignant cells, ensuring the highest accuracy in your results.
Who Should Consider This Test?
This test provides crucial information for:
- Breast cancer patients monitoring treatment response and potential recurrence
- Individuals with suspicious symptoms like persistent lumps, skin changes, or unusual breast pain
- Patients with family history of breast cancer seeking comprehensive monitoring
- Those experiencing unexplained weight loss, fatigue, or bone pain that might indicate metastasis
- Anyone needing clarity about their cancer status for treatment planning
Why This Test Matters for Your Health Journey
Early detection of metastasis can significantly impact your treatment success and quality of life. This test offers:
- Early intervention opportunities when treatment is most effective
- Personalised treatment planning based on your specific cancer characteristics
- Peace of mind through regular monitoring and clear results
- Reduced anxiety by replacing uncertainty with actionable information
- Improved communication with your healthcare team through comprehensive data
Understanding Your Results with Confidence
Your results will provide clear, understandable information about:
- Receptor status guiding hormone therapy suitability
- CA 15.3 levels indicating cancer activity and potential spread
- Pathology confirmation of malignant cell presence
Our team ensures you receive your results with appropriate context and guidance for discussing them with your oncologist. Most results are available within 5-7 days, with CA 15.3 available same-day when needed.
Affordable, Accessible Testing for Your Peace of Mind
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| Breast Metastatic Marker Test | ZAR 1,700 | ZAR 800 |
This investment in your health provides invaluable information that could save thousands in future treatment costs and, most importantly, contribute to better health outcomes.
Why Trust Oracle Genomics?
- Nationwide Coverage: Accessible testing centres across South Africa, including Johannesburg, Cape Town, Durban, and Pretoria
- Professional Expertise: All tests include pathologist review for maximum accuracy
- Advanced Methodology: Using Immunohistochemistry and Chemiluminescent Immunoassay for reliable results
- Patient-Focused Care: We understand the emotional journey and provide compassionate, clear communication
- Rapid Turnaround: Most results within 5-7 days, with same-day options available
Simple Sample Preparation
For accurate testing, please provide:
- Tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block
- A copy of your Histopathology report
- Complete clinical history
- Clear indication of biopsy site
Samples are shipped at room temperature with proper handling instructions.
Take the Next Step Toward Clarity
Don’t let uncertainty control your health journey. Our Breast Metastatic Marker Test provides the information you need to make confident decisions about your care.
Limited Time Special: Save ZAR 800 on your Breast Metastatic Marker Test. Early detection provides the best opportunity for successful treatment outcomes.
Nationwide Accessibility: Whether you’re in Johannesburg, Cape Town, Durban, or Pretoria, receive the same professional, compassionate care.
